Atlas FDA

ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS

FDA premarket approval P980041/S033 · decided 2015-07-08

Approval details

PMA number
P980041
Supplement
S033
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Applicant
Beckman Coulter, Inc.
Date received
2015-06-05
Decision date
2015-07-08
Days to decision
33 days
Decision code
OK30
Product code
LOK
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA
Statement
MANUFACTURING CHANGES TO THE PRODUCTION AND PURIFICATION PROCESS OF ANTIBODY, WHICH IS USED IN PREPARATION OF THE PARAMAGNETIC PARTICLES FOR USE IN THE ACCESS AFP REAGENT.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20